Cargando…
Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
BACKGROUND: Currently, there is no treatment for retinal degenerative diseases (RDD) such as retinitis pigmentosa (RP). Stem cell-based therapies could provide promising opportunities to repair the damaged retina and restore vision. Thus far, primarily adult mesenchymal stem cells (MSCs) have been i...
Autores principales: | Brown, Christina, Agosta, Patrina, McKee, Christina, Walker, Keegan, Mazzella, Matteo, Alamri, Ali, Svinarich, David, Chaudhry, G. Rasul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994263/ https://www.ncbi.nlm.nih.gov/pubmed/35395806 http://dx.doi.org/10.1186/s13287-022-02828-w |
Ejemplares similares
-
WNT and VEGF/PDGF signaling regulate self-renewal in primitive mesenchymal stem cells
por: Mazzella, Matteo, et al.
Publicado: (2023) -
Transcriptional Profiling Identifies Upregulation of Neuroprotective Pathways in Retinitis Pigmentosa
por: Bielmeier, Christina B., et al.
Publicado: (2021) -
Regulation of self-renewal and senescence in primitive mesenchymal stem cells by Wnt and TGFβ signaling
por: Mazzella, Matteo, et al.
Publicado: (2023) -
The potential role of integrin alpha 6 in human mesenchymal stem cells
por: Al-Obaide, Mohammed, et al.
Publicado: (2022) -
Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa
por: Sánchez-Cruz, Alonso, et al.
Publicado: (2018)